8 April 2025
Trajan Group (TRJ): Returning to Growth
We have initiated coverage on Trajan Group (TRJ) with a price target of $1.50 and a Buy recommendation.
17 February 2025
Pro Medicus (PME): Growth rate accelerating
PME’s growth in core radiology and cardiology services supports an upgraded Buy rating with a price target of $330.
22 October 2024
CSL Limited (CSL): Margin Recovery to Drive Earnings
We have initiated coverage on CSL Limited (CSL) with a price target of $345 and a Buy recommendation.
26 July 2024
MedAdvisor (MDR): Q4 Update On Track
MedAdvisor had another strong quarter of topline growth in the US and ANZ, while gross margins also improved.
20 December 2023
Neuren Pharmaceuticals (NEU): It Keeps Getting Better
NEU released impressive efficacy and safety results from the first of four single-arm Phase 2 trials evaluating NNZ-2591 (n=18).
19 February 2020
Health Care & Biotech Stock Picks for 2020
The fundamentals and demographic trends for the healthcare and biotech sector remained strong in 2019 and we expect some of the key themes from this year to continue to play out in 2020.